Science Explorer Back to mapMap
Discussion
Researcher · Taiho Pharmaceutical (Japan) · Japan

Hiroaki Ochiiwa

Hiroaki Ochiiwa publishes mostly in Molecular Biology, Oncology and Hepatology, on topics such as Ubiquitin and proteasome pathways, Fibroblast Growth Factor Research and Cancer, Hypoxia, and Metabolism.

ORCID 0000-0002-8243-0113 OpenAlex
World rank
#3,146,558
of 7,710,434 ranked researchers
Rank in Japan
#72,305
of 383,136
Works
53
Citations
429
Citations per work
8.1
h-index
7
i10-index 7Top 91% in Molecular Biology
Hiroaki Ochiiwa

What does Hiroaki Ochiiwa research?

Hiroaki Ochiiwa's work is mostly in Biochemistry, Genetics and Molecular Biology (53%), Medicine (22%).

Life Sciences: 28 works · 53.5% of their workBiochemistry, Genetics and Molecular Biology: 28 works · 53.5% of their workMolecular Biology: 22 works · 42.0% of their workCancer Research: 4 works · 7.2% of their workCell Biology: 2 works · 4.3% of their workEverything else: 13 works · 24.9% of their workHealth Sciences: 11 works · 21.6% of their workMedicine: 11 works · 21.6% of their workOncology: 5 works · 10.1% of their workHepatology: 4 works · 7.2% of their workPulmonary and Respiratory Medicine: 2 works · 4.3% of their workTHEIR WORKHiroaki Ochiiwa53works
Life Sciences53%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2853.5%
  2. Everything else1324.9%
    1. Medicine1121.6%
  1. 1Molecular Biology42% of their works
  2. 2Oncology10% of their works
  3. 3Hepatology7% of their works
  4. 4Cancer Research7% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Cell Biology4% of their works

Research topics

Which keywords describe Hiroaki Ochiiwa's research?

The keywords of their largest research topics: Cancer Therapy, Cancer, Mutation, FGF21, Fibroblast Growth Factor, Proteasome, Ubiquitin and Cell Cycle.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Therapy133 topics
  2. Cancer123 topics
  3. Mutation72 topics
  4. FGF2161 topic
  5. Fibroblast Growth Factor61 topic
  6. Proteasome61 topic
  7. Ubiquitin61 topic
  8. Cell Cycle41 topic
  9. HIF-141 topic
  10. Hepatic Stellate Cells41 topic
  11. Liver Regeneration41 topic
  12. Warburg Effect41 topic
  13. p5341 topic
  14. Cell Division31 topic
  15. DNA Damage31 topic
  16. Microtubules31 topic
  17. PTPN1131 topic
  18. Protein Tyrosine Phosphatases31 topic
  19. Repair31 topic

Where does Hiroaki Ochiiwa work?

Hiroaki Ochiiwa's main affiliation in the publication record is Taiho Pharmaceutical (Japan), Japan.

How many publications and citations does Hiroaki Ochiiwa have?

OpenAlex counts 53 works and 429 citations for Hiroaki Ochiiwa, an h-index of 7, ranking #3,146,558 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hiroaki Ochiiwa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.